Rigel Pharmaceuticals | 销售和管理费用

Selling And Administration Expenses 更改 日
Amgen USD 1.76B 424M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Celldex Therapeutics USD 8.83M 611K 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Ligand Pharmaceuticals USD 15.99M 1.34M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Veracyte USD 49.06M 9.55M 2023-12



Rigel Pharmaceuticals 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.